Anheuser-Busch InBev SA/NV (NYSE:BUD) does about 1.31M shares in volume on a normal day but saw 1610379 shares change hands in Monday trading. The company now has a market cap of 102.67B USD. Its current market price is $59.30, marking a decrease of -0.84% compared to the previous close of $59.80. The 52 week high reached by this stock is $66.07 whilst the lowest price level in 52 weeks is $44.51. The script in recent trading has seen the stock touch a high of $59.705 and a low of $59.0175.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Anheuser-Busch InBev SA/NV (BUD) has a 20-day trading average at $60.33 and the current price is -10.25% off the 52-week high compared with 33.23% distance from its 52-week low. The 50-day simple moving average of the closing price is $58.80 and its 200-day simple moving average is $54.21. If we look at the stock’s price movements over the week, volatility stands at 1.53%, which decreases to 1.29% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 47.49 to suggest the stock is neutral.
30 analysts observing the Anheuser-Busch InBev SA/NV (BUD) stock have set the 12-month price targets for the company’s shares at between $59.00 and $71.00. The consensus objective for the share price is $64.14, suggesting that the stock has a potential upside of 7.55% over the period. The median price target is 7.34% away from the current levels at $64.00.
FactSet Research has provided data showing that 30 brokerages have issued ratings for the stock. 3 analysts have rated it as a sell, while 2 advise that it is a overweight. 17 analysts have rated it as a buy and 8 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.
JP Morgan upgraded its price target at $45-$70.
The current price level is -1.80%, 1.08%, and 9.38% away from its SMA20, SMA50, and SMA200 respectively, with the BUD price moving above the 50-day SMA on January 23. Anheuser-Busch InBev SA/NV (BUD) stock is down -2.66% over the week and -0.12% over the past month. Its price is -1.23% year-to-date and -9.59% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of $0.84 above consensus estimates by $0.07. BUD’s earnings per share are forecast to grow by 2.50% this year and 14.00% over next year. Expected sales for next quarter are $13.82 billion, which analysts say will come at $58.58 billion for the current fiscal year and next year at $61.54 billion. In addition, estimates put the company’s current quarterly revenue at an average of $15.15 billion.
To reach the target analysts have set, the stock logically needs to grow 7.55 percent from here.
Outstanding shares total 1.70B with insiders holding 0.00% of the shares and institutional holders owning 6.46% of the company’s common stock. The company has a return on investment of 6.80% and return on equity of 7.30%. The price to earnings ratio (P/E ratio) amounts to 24.13 while the forward price to earnings ratio is 18.02. The beta has a value of 1.24. Price to book ratio is 9.84 and price to sales ratio is 1.79.
